Simplified monitoring post-treatment.
- Conditions
- Post-treatmentCervical Intraepithelial Neoplasia (CIN)Human papillomavirus (HPV)methylation markers in Dutch: Cervicale Intraepitheliale Neoplasie (CIN)Humaan papillomavirus (HPV)methyleringsmarkersfollow-up
- Registration Number
- NL-OMON27229
- Lead Sponsor
- HumaVac (VU medical Center)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 360
Inclusion Criteria
1. A histological confirmed CIN2/3 lesion that will be treated by cone biopsy or colposcopic guided LLETZ;
2. Written informed consent prior to enrolment;
Exclusion Criteria
1. The subject is pregnant (or has been in the last three months);
2. The subject has received prophylactic (or therapeutic) HPV- vaccination;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main study parameter is the histological confirmed recurrence of a high-grade lesion in the study population from the moment of treatment until exit-colposcopy.
- Secondary Outcome Measures
Name Time Method